BioSpace News Archive

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Dr. Sachin Shridharani to its Scientific Advisory Board, effective immediately.

Savara to Present at the 40 th Annual Canaccord Genuity Global Growth Conference to be Held Virtually

Blade Therapeutics, a leader in the fields of fibrosis, COVID-19 pathogenesis and inflammatory biology, today announced the appointment of Mark Timney as Chairman of the Board of Directors. Mr. Timney succeeds Luke Evnin, Ph.D., co-founder and Managing Director of MPM, who has served as Chairman since the founding of Blade Therapeutics in 2015. Dr. Evnin will remain a member the Board of Directors, which will

Evotec SE will report its financial results for the first half-year of 2020 on Wednesday, 12 August 2020.

Vyripharm International, Inc., is a subsidiary of Vyripharm Enterprises, LLC, a privately held company formed for Partnerships and Joint Ventures with International Public or Private Organizations.

Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: PDDPF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Wednesday, August 12, 2020 to discuss the Company’s financial results for the fiscal 2021 first quarter ended June 30, 2020, as well as the Company’s corporate progress and other developments. The Company expects to file its financial statements along with its MD&A post market on

The global market for viral conjunctivitis pipeline drugs is competitive in nature and is expected to observe a substantial rise in the level of competition in the next few years, thanks to the rising number of players projected to enter the market, states a new market intelligence study by Transparency Market Research.

Transparency Market Research has published a new report titled, ‘Topical Pain Management Therapeutics in Sports Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Transparency Market Research has published a new report titled, ‘Sterilization Equipment and Disinfectant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

The global Methicillin-resistant Staphylococcus Aureus Drugs Market was valued at approximately US$ 2.9 Bn in 2016 is projected to register cumulative annual growth rate of over 3.2% from 2017 to 2025, according to a new report published by Transparency Market Research titled “Methicillin-resistant Staphylococcus Aureus Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”.